Suppr超能文献

在柯萨奇病毒B3诱导的心肌炎期间,抑制凝血因子Xa可改善心肌功能。

Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.

作者信息

Malz Ronny, Weithauser Alice, Tschöpe Carsten, Schultheiss Heinz-Peter, Rauch Ursula

机构信息

Centrum für Herz- und Kreislaufmedizin, Medizinische Klinik II, Charité - Universitätsmedizin Berlin Campus Benjamin Franklin, Berlin, Germany.

出版信息

Cardiovasc Ther. 2014 Jun;32(3):113-9. doi: 10.1111/1755-5922.12069.

Abstract

INTRODUCTION

Myocarditis is induced by coxsackievirus B3 (CVB3). Myocardial inflammation is tied to the activation of coagulation. Coagulation factor (F) Xa, a central player in coagulation, activates matrix metalloproteinases (MMP), which modulate the remodeling.

AIMS

In this study, we investigated the effects of pharmacological FXa inhibition on myocardial function, inflammation, and remodeling during a CVB3-induced myocarditis.

METHODS AND RESULTS

Immune cells and matrix proteins were detected by immunohistochemistry. The expression of cytokines was measured by real-time PCR and the activity of MMP-2 by zymography. Left ventricular function was analyzed using microconductance pressure catheter. Treatment with the FXa inhibitor fondaparinux led to an improved left ventricular function in CVB3-induced mice compared to saline-treated controls (dPdtmax: fondaparinux 4632 ± 499.6 vs. saline 3131 ± 374.0 [mmHg/s], P = 0.0503; SV: fondaparinux 33.19 ± 4.893 vs. saline 19.32 ± 2.236 [μL], P < 0.118; CO: fondaparinux 15124 ± 2183 vs. saline 8088 ± 1035 [μL/min], P < 0.05). Therapy with fondaparinux reduced the activity of MMP-2 (fondaparinux 1.208 ± 0.1247 vs. saline 1.565 ± 0.05476, P < 0.05). The collagen type I/III ratio as well as the expression of TIMP-1 was comparable in both infection groups postinfectionem (p.i.), despite an increased infiltration of macrophages into the hearts of mice treated with fondaparinux 8 days p.i. (CD68+: fondaparinux 494.2 ± 64.73 vs. saline 306.9 ± 43.73 [cells/mm(2) ], P < 0.05). Anti-inflammatory CD206-positive M2-type macrophages were increased in the infected hearts after fondaparinux treatment (CD206+: fondaparinux 182.1 ± 18.18 vs. saline 111.6 ± 21.07 [cells/mm(2) ], P < 0.05), whereas CD80-positive M1-type macrophages were comparable in both groups.

CONCLUSION

In conclusion, selective inhibition of FXa improves the left ventricular function during CVB3-induced myocarditis and seems to be associated with an improved myocardial remodeling.

摘要

引言

柯萨奇病毒B3(CVB3)可诱发心肌炎。心肌炎症与凝血激活有关。凝血因子(F)Xa是凝血过程中的关键因子,可激活基质金属蛋白酶(MMP),后者参与调节心肌重塑。

目的

在本研究中,我们探究了药物性抑制FXa对CVB3诱发心肌炎期间心肌功能、炎症及重塑的影响。

方法与结果

通过免疫组织化学检测免疫细胞和基质蛋白。采用实时聚合酶链反应测定细胞因子表达,用酶谱法检测MMP-2活性。使用微电导压力导管分析左心室功能。与生理盐水处理的对照组相比,用FXa抑制剂磺达肝癸钠治疗可改善CVB3诱发小鼠的左心室功能(dPdtmax:磺达肝癸钠4632±499.6 vs.生理盐水3131±374.0[mmHg/s],P = 0.0503;SV:磺达肝癸钠33.19±4.893 vs.生理盐水19.32±2.236[μL],P < 0.118;CO:磺达肝癸钠15124±2183 vs.生理盐水8088±1035[μL/min],P < 0.05)。磺达肝癸钠治疗降低了MMP-2活性(磺达肝癸钠1.208±0.1247 vs.生理盐水1.565±0.05476,P < 0.05)。尽管感染后8天用磺达肝癸钠治疗的小鼠心脏中巨噬细胞浸润增加(CD68+:磺达肝癸钠494.2±64.73 vs.生理盐水306.9±43.73[细胞/mm²],P < 0.05),但感染后两组的I/III型胶原比例以及TIMP-1表达相当。磺达肝癸钠治疗后感染心脏中抗炎性CD206阳性M2型巨噬细胞增加(CD206+:磺达肝癸钠182.1±18.18 vs.生理盐水111.6±21.07[细胞/mm²],P < 0.05),而两组中CD80阳性M1型巨噬细胞相当。

结论

总之,选择性抑制FXa可改善CVB3诱发心肌炎期间的左心室功能,且似乎与改善心肌重塑有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验